BMJ 2005;330:1382-1384 (11 June), doi:10.1136/bmj.330.7504.1382
Education and debate
Prognosis without treatment as a modifier in health economic assessments
Ross Camidge, clinical lecturer in cancer therapeutics1,
Andrew Walker, senior lecturer in health economics2,
James J Oliver, clinical lecturer in clinical pharmacology and therapeutics1,
Fiona Nussey, clinical lecturer in medical oncology3,
Simon Maxwell, senior lecturer in clinical pharmacology and therapeutics1,
Duncan Jodrell, reader in oncology3,
David J Webb, professor of clinical pharmacology and therapeutics1
1 Clinical Pharmacology Unit, Western General Hospital, Edinburgh EH4 2XU,
2 Robertson Centre for Biostatistics, University of Glasgow, Glasgow G12 8QQ,
3 Edinburgh Cancer Centre, Western General Hospital
Correspondence to: R Camidge drcamidge@talk21.com
How long someone has to live intuitively seems important in rationing decisions. Incorporating it into economic assessments, as described here, could make decisions fairer
| The first 150 words of the full text of this article appear below. |
Introduction
Explicit rationingdecisions not to fund certain treatmentshas
become a fact of life in many healthcare systems.
1-4 Health
economic assessments often underpin rationing decisions, although
it remains unclear whether society's values are well reflected
by the utilitarian approach of maximising the units of health
attainable from available resources.
5
6 Health economic assessments
are used to determine the additional cost per unit of health
gain for different treatment options. Cost effectiveness analysis
is the most common method of assessment
7
8 and, for life shortening
conditions, primarily focuses on the additional cost per life
year gained. We propose that prognosis without treatment is
an important contextual modifier of life years gained in evaluating
treatments for life shortening conditions. We present initial
data supporting this hypothesis and describe resource allocation
strategies that use this information.
Limitations of life years gained
Life years gained represent the extra life expectancy resulting
from a treatment. By definition, the comparison is with the
life expectancy
. . . [Full text of this article]
QALYs and contextual modifiers
Evidence for use of prognosis without treatment
What further work is required?

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Relevant Articles
-
A middle way for rationing healthcare resources
- Rudolf Klein
BMJ 2005 330: 1340-1341.
[Extract]
[Full Text]
[PDF]
-
Is economic evaluation in touch with society's health values?
- Joanna Coast
BMJ 2004 329: 1233-1236.
[Extract]
[Full Text]
[PDF]
-
National Institute for Clinical Excellence and its value judgments
- Michael D Rawlins and Anthony J Culyer
BMJ 2004 329: 224-227.
[Extract]
[Full Text]
[PDF]
-
Challenges for the National Institute for Clinical Excellence
- Alan Maynard, Karen Bloor, and Nick Freemantle
BMJ 2004 329: 227-229.
[Extract]
[Full Text]
[PDF]
-
The rationing debate: Rationing health care by age: The case for
- Alan Williams
BMJ 1997 314: 820.
[Extract]
[Full Text]
-
The rationing debate: Rationing health care by age: The case against
- J Grimley Evans
BMJ 1997 314: 822.
[Extract]
[Full Text]
This article has been cited by other articles:
-
Klein, R.
(2005). A middle way for rationing healthcare resources. BMJ
330: 1340-1341
[Full text]